Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Immunology
Импакт фактор: 1.352 5-летний Импакт фактор: 3.347 SJR: 1.022 SNIP: 0.55 CiteScore™: 2.19

ISSN Печать: 1040-8401
ISSN Онлайн: 2162-6472

Выпуски:
Том 39, 2019 Том 38, 2018 Том 37, 2017 Том 36, 2016 Том 35, 2015 Том 34, 2014 Том 33, 2013 Том 32, 2012 Том 31, 2011 Том 30, 2010 Том 29, 2009 Том 28, 2008 Том 27, 2007 Том 26, 2006 Том 25, 2005 Том 24, 2004 Том 23, 2003 Том 22, 2002 Том 21, 2001 Том 20, 2000 Том 19, 1999 Том 18, 1998 Том 17, 1997 Том 16, 1996 Том 15, 1995 Том 14, 1994

Critical Reviews™ in Immunology

Купить выпуск $153.00 Том 27, 2007 Выпуск 5

DOI: 10.1615/CritRevImmunol.v27.i5

Содержание:

PART IV. Cytokine and Hormone Immunotherapy
Treatment of AIDS-Related Kaposi's Sarcoma with Interleukin-12: Rationale and Preliminary Evidence of Clinical Activity

Robert Yarchoan, James M. Pluda, Kathleen M. Wyvill, Karen Aleman, Isaac R. Rodriguez-Chavez, Giovanna Tosato, Andrew T. Catanzaro, Seth M. Steinberg, Richard F. Little
pages 401-414
DOI: 10.1615/CritRevImmunol.v27.i5.10
Targeting OX40 and OX40L for the Treatment of Autoimmunity and Cancer
William L. Redmond, Andrew D. Weinberg
pages 415-436
DOI: 10.1615/CritRevImmunol.v27.i5.20
Gene Expression Signatures of Interleukin-2 In Vivo and In Vitro and Their Relation to Anticancer Therapy
Ping Jin, Ena Wang, Maurizio Provenzano, David Stroncek, Francesco M. Marincola
pages 437-448
DOI: 10.1615/CritRevImmunol.v27.i5.30
PART V. Modulation of Antitumor Vaccine Strategies
Preclinical and Clinical Studies of Recombinant Poxvirus Vaccines for Carcinoma Therapy

Philip M. Arlen, James L. Gulley, Ravi A. Madan, James W. Hodge, Jeffrey Schlom
pages 451-462
DOI: 10.1615/CritRevImmunol.v27.i5.40
Immunogenicity of Dendritic-Tumor Fusion Hybrids and Their Utility in Cancer Immunotherapy
Suyu Shu, Rongxiu Zheng, Walter T. Lee, Peter A. Cohen
pages 463-483
DOI: 10.1615/CritRevImmunol.v27.i5.50
Improving Immunotherapy by Conditionally Enhancing MHC Class I Presentation of Tumor Antigen-Derived Peptide Epitopes
Walter J. Storkus, Christopher Herrem, Mayumi Kawabe, Peter A. Cohen, Ronald M. Bukowski, James H. Finke, Amy K. Wesa
pages 485-493
DOI: 10.1615/CritRevImmunol.v27.i5.60

Critical Reviews™ in Immunology

Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Viral Mechanisms Involved in the Transcriptional CBP/р300 Regulation of Inflammatory and Immune Responses
Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Exosome Release by Primary B Cells
Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Biology of Granzyme M: A Serine Protease with Unique Features
(A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. (A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30, Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30,  Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling